Diagnosing cancer in English community pharmacies
BMJ
.
2024 May 13:385:e077087.
doi: 10.1136/bmj-2023-077087.
Authors
Stephen H Bradley
1
,
Daniel Jones
2
3
,
Su Wood
2
,
Meena Rafiq
4
5
,
Carolyn Bradley
6
,
William T Hamilton
7
Affiliations
1
Academic Unit of Primary Care, University of Leeds, UK medsbra@leeds.ac.uk.
2
Academic Unit of Primary Care, University of Leeds, UK.
3
North Cumbria Integrated Care NHS Foundation Trust, Carlisle, UK.
4
Centre for Cancer Research and Department of General Practice, University of Melbourne, Australia.
5
Epidemiology of Cancer and Healthcare Outcomes (ECHO) group, University College London, UK.
6
Patient author, Leeds, UK medsbra@leeds.ac.uk.
7
Department of Health and Community Sciences, Faculty of Health and Life Sciences, University of Exeter, UK.
PMID:
38740425
DOI:
10.1136/bmj-2023-077087
No abstract available
Publication types
Editorial
MeSH terms
Community Pharmacy Services*
Early Detection of Cancer
England / epidemiology
Humans
Neoplasms* / diagnosis
Pharmacies